Lv1
70 积分 2025-06-20 加入
A real-world experience with ranibizumab 0.5 mg initial intensive treatment for diabetic macular edema: 24-week outcomes of the RISING-K study
3个月前
已完结
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
3个月前
已完结
Real-World Outcomes in Eyes with Neovascular AMD Switched from Brolucizumab to Faricimab: A TRUCKEE Study Analysis
3个月前
已完结
Comparative efficacy and safety of faricimab, aflibercept, conbercept, and ranibizumab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
3个月前
已完结
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
3个月前
已完结
Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis
4个月前
已完结
Choroidal vascularity index as a marker of health and disease: systematic review and meta-analyses
4个月前
已完结
Age-related choroidal atrophy: A systematic review of multimodal imaging, clinical features, and differentiation from other forms of macular degeneration
4个月前
已完结
皖公网安备34019202002308
